The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: A 3-month clinical trial

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 2, 2003, Pages 155-160

  Inan, Ümit Übeyt ^a   Ermis, Sitki Samet ^a   Yücel, Aylin ^a   Öztürk, Faruk ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Brimonidine; Colour Doppler imaging; Intraocular pressure; Latanoprost; Retrobulbar blood flow

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LATANOPROST;

ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOPPLER ECHOGRAPHY; EYE BLOOD FLOW; HEART RATE; HEMODYNAMICS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; OPHTHALMIC ARTERY; OPTIC DISK ANOMALY; PERFUSION PRESSURE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; STATISTICAL SIGNIFICANCE; SYSTOLE; VISUAL IMPAIRMENT;

BLOOD FLOW VELOCITY; CILIARY ARTERIES; EYE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPHTHALMIC ARTERY; PROSTAGLANDINS F, SYNTHETIC; QUINOXALINES; RETINAL ARTERY; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR RESISTANCE;

EID: 0037620626     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2003.00049.x     Document Type: Article

References (37)

1. Bergstrand IC, Heijl A & Harris A (2002): Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study. Acta Ophthalmol Scand 80: 176-182.
2. Bergstrand IC, Heijl A, Wollmer P, Hansen F & Harris A (2001): Timolol increased retrobulbar flow velocities in untreated glaucoma eyes but not in ocular hypertension. Acta Ophthalmol Scand 79: 455-461.
3. Burke J & Schwartz M (1996): Preclinical evaluation of brimonidine. Surv Ophthalmol 41: S9-S18,
4. 2-adrenergic agonist in ophthalmology. J Glaucoma 4: S30-S35.
5. Camras CB, Alm A, Watson P & Stjernschantz J (1996): Latanoprost, a prostaglandin analogue, for glaucoma therapy. Ophthalmology 103: 1916-1924.
6. Carenini BB, Brogliatti B, Carenini AB, Sibour G & Demarie G (1993): Ischaemia and glaucoma. New Trends Ophthalmol 8: 75-80.
7. Carlson AM, Chauhan BC, Lee AA & LeBlanc RP (2000): The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension. Am J Ophthalmol 129: 297-301.
8. Chung HS, Harris A & Evans D (1999): Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43: S43-S50.
9. Drance SM, Crichton A & Mills RP (1998): Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal tension glaucoma. Am J Ophthalmol 125: 585-592.
10. Georgopoulos GT, Diestelhorst M, Fisher R, Ruokomen P & Krieglstein GK (2002): The short-term effects of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta Ophthalmol Scand 80: 54-58.
11. Geyer O, Man O, Weintraub M & Silver DM (2001): Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol 131: 198-202.
12. Graham SL, Drance SM, Wijsman K, Douglas GR & Mikelberg FS (1995): Ambulatory blood pressure monitoring in glaucoma: the nocturnal dip. Ophthalmology 102: 61-69.
13. Greve EL, Rulo AH, Drance SM, Crichton AC, Mills RP & Hoyng PFJ (1997): Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimes of latanoprost treatment. Surv Ophthalmol 41 (Suppl 2): 89-92.
14. 2-adrenoreceptor agonist for glaucoma treatment. J Glaucoma 6: 250-258.
15. Harris A, Arend O, Chung HS, Kagemann L, Cantor L & Martin B (2000): A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal tension glaucoma patients. Ophthalmology 107: 430-434.
16. Harris A, Joos K & Kay M (1996): Acute IOP elevation with scleral suction: effects on retrobulbar haemodynamics. Br J Ophthalmol 80: 1-5.
17. Harris A, Spaeth GL, Sergott RC, Katz LJ, Cantor LB & Martin BJ (1995): Retrobulbar arterial haemodynamic effects of betaxolol and timolol in normal tension glaucoma. Am J Ophthalmol 120: 168-175.
18. Ishii K, Tomidokoro A, Nagahara. M, Tamaki Y, Kanno M, Fukaya Y & Araie M (2001): Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 42: 2957-2963.
19. Jonescu-Cuypers CP, Harris A & Ishii Y (2001): Effect of brimonidine tartrate on ocular haemodynamics in healthy volunteers. J Ocul Pharmacol Ther 17: 199-205.
20. Joos KM, Kay MD & Pillunat LE (1999): The effect of acute intraocular pressure changes on short posterior ciliary artery haemo-dynamics. Br J Ophthalmol 83: 33-38.
21. Kaiser HJ, Schoetzau A, Stümpfig D & Flammer J (1997): Blood-flow velocities of the extraocular vessels in patients with high tension and normal tension primary open-angle glaucoma. Am J Ophthalmol 123: 320-327.
22. Kjellgren D, Douglas G, Mikelberg FS, Drance SM & Alm A (1995): The short time effect of latanoprost on the intraocular pressure in normal pressure glaucoma. Acta Ophthalmol Scand 73: 233-236.
23. Lachkar Y, Migdal C & Dhanjil S (1998): Effect of brimonidine tartrate on ocular haemodynamic measurements. Arch Ophthalmol 116: 1591-1594.
24. Marcello TN, Peter H, Stephan MD, Nicolea MT, Hnik P & Drance SM (1996): Scanning laser Doppler flowmeter study of retinal and optic disc blood flow in glaucomatous patients. Am J Ophthalmol 122: 775-783.
25. McKibbin M & Menage MJ (1999): The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 13: 31-34.
26. Nicolea MT, Buckley AR, Walman BE & Drance SM (1996a): A comparative study of the effects of timolol and latanoprost on blood flow velocity of retrobulbar vessels. Am J Ophthalmol 122: 784-789.
27. Nicolea MT, Walman BE, Buckley AR & Drance SM (1996b): Various glaucomatous optic nerve appearances. A colour Doppler imaging study of retrobulbar circulation. Ophthalmology 103: 1670-1679.
28. Nordlund JR, Pasquale LR & Robin AL (1995): The cardiovascular, pulmonary and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol 113: 77-83.
29. Robert D, Steigerwalt JR, Belcaro GV & Giuseppe L (1998): Ocular and orbital blood flow in patients with essential hypertension treated with trandolapril. Retina 18: 539-545.
30. Schuman JS (1996): Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol 41: S27-S37.
31. Seong GJ, Lee HK & Hong YJ (1999): Effects of 0.005% latanoprost optic nerve head and peripapillary retinal blood flow. Ophthalmologica 213: 355-359.
32. Stjernschantz J, Selen G, Astin M, Karlsson M & Resul B (1999): Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye. Arch Ophthalmol 117: 1363-1367.
33. Tamaki Y, Nagahara M, Araie M, Tomita K, Sandoh S & Tomidokoro A (2001): Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther 17: 403-411.
34. Vetrugno M, Cantatore F, Gigante G & Cardia L (1998): Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow. Acta Ophthalmol Scand 227: 40-41.
35. Vetrugno M, Maino A, Cantatore F, Ruggeri G & Cardia L (2001): Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an openlabel, uncontrolled, prospective study. Clin Ther 23: 1519-1528.
36. Walters TR (1996): Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose-response and dosing studies. Surv Ophthalmol 41: S19-S26.
37. Wilensky JT (1996): The role of brimonidine in the treatment of open-angle glaucoma. Surv Ophthalmol 41 (Suppl): 3-7.